U.S. markets open in 5 hours 29 minutes

Acorda Therapeutics, Inc. (ACOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.7402-0.0004 (-0.05%)
At close: 4:00PM EDT

0.7200 -0.02 (-2.73%)
Before hours: 4:00AM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/11/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
35.52M35.25M44.49M97.31M136.36M369.15M
Enterprise Value 3
222.47M202.61M171.48M227.73M222.50M406.27M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
0.220.200.230.460.450.89
Price/Book (mrq)
0.120.110.140.350.250.64
Enterprise Value/Revenue 3
1.396.036.104.514.668.12
Enterprise Value/EBITDA 6
-1.04-11.9541.092.84-0.89-34.24

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-72.89%
S&P500 52-Week Change 316.25%
52 Week High 34.4600
52 Week Low 30.6000
50-Day Moving Average 30.7326
200-Day Moving Average 31.0425

Share Statistics

Avg Vol (3 month) 32.65M
Avg Vol (10 day) 33.17M
Shares Outstanding 547.98M
Float 43.11M
% Held by Insiders 11.49%
% Held by Institutions 1116.94%
Shares Short (Jul 14, 2020) 49.59M
Short Ratio (Jul 14, 2020) 44.58
Short % of Float (Jul 14, 2020) 422.69%
Short % of Shares Outstanding (Jul 14, 2020) 419.98%
Shares Short (prior month Jun 14, 2020) 410.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin -138.66%
Operating Margin (ttm)-63.36%

Management Effectiveness

Return on Assets (ttm)-6.58%
Return on Equity (ttm)-53.07%

Income Statement

Revenue (ttm)159.93M
Revenue Per Share (ttm)3.36
Quarterly Revenue Growth (yoy)-32.80%
Gross Profit (ttm)157.56M
EBITDA -62.08M
Net Income Avi to Common (ttm)-221.77M
Diluted EPS (ttm)-4.6620
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)65.99M
Total Cash Per Share (mrq)1.38
Total Debt (mrq)252.94M
Total Debt/Equity (mrq)86.95
Current Ratio (mrq)1.14
Book Value Per Share (mrq)6.10

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A